BridgeBio Pharma

About BridgeBio Pharma

BridgeBio Pharma is a biopharmaceutical company focused on developing precision medicines for genetic diseases and cancers with clear genetic drivers. The company primarily serves patients with rare genetic disorders through its pipeline of targeted therapies. Their main products include investigational treatments for conditions such as achondroplasia, transthyretin amyloidosis, and various genetic cancers. As a distributed organization, BridgeBio operates with remote-friendly policies that allow scientific and operational teams to collaborate across multiple locations while advancing their mission to transform patients' lives.

Company Culture

BridgeBio fosters a collaborative, mission-driven culture where teams work across disciplines to advance drug development. The environment emphasizes scientific rigor, innovation, and patient-centric focus, with distributed teams leveraging technology for effective collaboration. Employees typically describe the culture as fast-paced and intellectually challenging, with a strong emphasis on translating genetic insights into meaningful therapies.

Our Values

Patient-first approach, scientific excellence, urgency in development, collaborative innovation, integrity in research, and transformative impact on genetic diseases.

Benefits & Perks

Typical benefits include comprehensive health insurance, remote work flexibility, competitive compensation with equity participation, professional development opportunities, and wellness programs. The company supports distributed teams with technology stipends and fosters work-life balance through flexible scheduling. Additional perks may include parental leave, retirement plans, and access to cutting-edge research resources.

Roles & Teams We Hire For

Skills & Tools You'll Use

Open Positions (1)